Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114057717B introduces a novel quinoline-substituted bisoxazoline ligand achieving high enantioselectivity in asymmetric catalysis with mild industrial-scale synthesis conditions.
Breakthrough catalytic method enables high-yield production of complex branched allyl intermediates with improved purity and reduced manufacturing costs.
Novel one-pot method for high-yield quinoline ester production ensures supply chain reliability and cost reduction in pharmaceutical manufacturing.
Patent CN113880781B enables efficient glucose-based synthesis of trifluoromethyl triazoles with enhanced supply chain reliability and sustainable manufacturing advantages.
Novel chiral indolinopyrrole synthesis via phosphoric acid catalysis achieves high enantioselectivity and scalability, enabling cost-effective API intermediate production for oncology therapeutics.
Patent CN106188044A details an iodine-catalyzed method for synthesizing thiolated imidazo[1,5-a]N-heterocycles without transition metals, enabling mild conditions and broad substrate scope for reliable pharmaceutical intermediate supply.
Patent CN118702710B introduces catalyst-free visible light synthesis enabling sustainable scale-up of high-purity organoboron compounds with significant cost reduction potential.
Patent CN110452150B enables one-step synthesis of axial chiral indole-naphthalene compounds under mild conditions with high optical purity, offering significant cost reduction and reliable supply for pharmaceutical catalysis applications.
Novel axial chiral phosphine-ene ligand enables mild-condition asymmetric allylation with high yield and enantioselectivity, ensuring reliable supply chain for pharmaceutical intermediates.
Patent CN116768812A introduces a novel catalytic method for multi-substituted dihydrooxazoles with high yield and simplified process flow enabling significant cost reduction and enhanced supply chain reliability for flavor and agrochemical applications.
Patent CN107188781A enables high-enantioselectivity isopulegol production under mild conditions with simplified catalyst recovery for cost-effective flavor intermediate manufacturing.
Breakthrough chiral phosphoric acid catalyst with spiro-bis-dihydrobenzothiole skeleton enables high-enantioselectivity asymmetric synthesis for pharmaceutical intermediates, offering reliable supply chain and cost reduction.
Novel copper-silver catalyzed synthesis enables mild condition production of high-purity pharmaceutical intermediates with simplified purification and enhanced supply chain reliability.
Novel chiral phosphoric acid-catalyzed synthesis achieves high enantioselectivity and yield for N-N axis pyrrole derivatives, enabling cost-effective pharmaceutical production with enhanced supply chain reliability.
Patent CN106045914A introduces a novel silver-catalyzed method for tri-substituted imidazole synthesis under mild conditions, enhancing purity and scalability while reducing supply chain complexity in pharmaceutical manufacturing.
Patent CN118666838B enables high-purity chiral intermediates through copper-catalyzed asymmetric synthesis, offering streamlined manufacturing and enhanced supply chain reliability for pharmaceutical applications.
Patent CN114478245A enables high-purity chiral intermediates with streamlined manufacturing and enhanced supply chain resilience for pharmaceutical applications.
Patent CN112961086A introduces a novel rhodium-catalyzed one-step synthesis method for high-purity pharmaceutical intermediates with significant cost reduction potential through streamlined manufacturing processes.
Novel copper-catalyzed synthesis enables high-purity aminoquinazolinone intermediates with enhanced scalability and reduced production costs for pharmaceutical manufacturing.
Patent CN113880781B enables high-purity triazole synthesis using biomass glucose with mild conditions and scalable manufacturing advantages.